Immune Checkpoint Inhibitors and Cardiac Toxicity in Patients Treated for Non-Small Lung Cancer: A Review

Lung cancer is a major cause of cancer-related mortality worldwide, both in men and women. The vast majority of patients are diagnosed with non-small-cell lung cancer (NSCLC, 80–85% of lung cancer cases). Therapeutics named immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sławiński, Grzegorz, Wrona, Anna, Dąbrowska-Kugacka, Alicja, Raczak, Grzegorz, Lewicka, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582741/
https://www.ncbi.nlm.nih.gov/pubmed/33003425
http://dx.doi.org/10.3390/ijms21197195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582741/
https://www.ncbi.nlm.nih.gov/pubmed/33003425
http://dx.doi.org/10.3390/ijms21197195

Ejemplares similares